Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 1239

1.

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.

Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, Thanendrarajan S, Schinke C, Samant R, Yaccoby S, Walker B, Epstein J, Zangari M, van Rhee F, Meissner T, Goldschmidt H, Hemminki K, Houlston R, Barlogie B, Davies FE, Morgan GJ, Weinhold N.

Blood. 2017 Apr 21. pii: blood-2017-03-774422. doi: 10.1182/blood-2017-03-774422. [Epub ahead of print]

PMID:
28432222
2.

Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.

Hirvonen EAM, Pitkänen E, Hemminki K, Aaltonen LA, Kilpivaara O.

Hum Genomics. 2017 Apr 20;11(1):6. doi: 10.1186/s40246-017-0102-x.

3.

Inherited variants in genes somatically mutated in thyroid cancer.

Campo C, Köhler A, Figlioli G, Elisei R, Romei C, Cipollini M, Bambi F, Hemminki K, Gemignani F, Landi S, Försti A.

PLoS One. 2017 Apr 14;12(4):e0174995. doi: 10.1371/journal.pone.0174995. eCollection 2017.

4.

Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.

Sud A, Thomsen H, Sundquist K, Houlston RS, Hemminki K.

J Clin Oncol. 2017 Mar 13:JCO2016709709. doi: 10.1200/JCO.2016.70.9709. [Epub ahead of print]

PMID:
28384078
5.

Genome-wide association study on monoclonal gammopathy of unknown significance (MGUS).

Thomsen H, Campo C, Weinhold N, Filho MI, Pour L, Gregora E, Vodicka P, Vodickova L, Hoffmann P, Nöthen MM, Jöckel KH, Langer C, Hajek R, Goldschmidt H, Hemminki K, Försti A.

Eur J Haematol. 2017 Apr 4. doi: 10.1111/ejh.12892. [Epub ahead of print]

PMID:
28375557
6.

Power and limits of modern cancer diagnostics: cancer of unknown primary.

Hemminki K, Liu H, Hemminki A, Sundquist J.

Ann Oncol. 2017 Mar 27. doi: 10.1093/annonc/mdx057. [Epub ahead of print] No abstract available.

PMID:
28368513
7.

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.

Granzow M, Hegenbart U, Hinderhofer K, Hose D, Seckinger A, Bochtler T, Hemminki K, Goldschmidt H, Schönland SO, Jauch A.

Haematologica. 2017 Mar 24. pii: haematol.2016.160721. doi: 10.3324/haematol.2016.160721. [Epub ahead of print]

8.

Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.

Campo C, da Silva Filho MI, Weinhold N, Mahmoudpour SH, Goldschmidt H, Hemminki K, Merz M, Försti A.

Hematol Oncol. 2017 Mar 20. doi: 10.1002/hon.2391. [Epub ahead of print]

PMID:
28317148
9.

Functional germline variants in driver genes of breast cancer.

Göhler S, Da Silva Filho MI, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P, Försti A.

Cancer Causes Control. 2017 Apr;28(4):259-271. doi: 10.1007/s10552-017-0849-3. Epub 2017 Feb 25.

PMID:
28238063
10.

Risk of other Cancers in Families with Melanoma: Novel Familial Links.

Frank C, Sundquist J, Hemminki A, Hemminki K.

Sci Rep. 2017 Feb 15;7:42601. doi: 10.1038/srep42601.

11.

Familial associations of lymphoma and myeloma with autoimmune diseases.

Hemminki K, Försti A, Sundquist K, Sundquist J, Li X.

Blood Cancer J. 2017 Jan 6;7(1):e515. doi: 10.1038/bcj.2016.123.

12.

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Law PJ, Sud A, Mitchell JS, Henrion M, Orlando G, Lenive O, Broderick P, Speedy HE, Johnson DC, Kaiser M, Weinhold N, Cooke R, Sunter NJ, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Carmichael J, Bailey JR, Pratt G, Rahman T, Pepper C, Fegan C, von Strandmann EP, Engert A, Försti A, Chen B, Filho MI, Thomsen H, Hoffmann P, Noethen MM, Eisele L, Jöckel KH, Allan JM, Swerdlow AJ, Goldschmidt H, Catovsky D, Morgan GJ, Hemminki K, Houlston RS.

Sci Rep. 2017 Jan 23;7:41071. doi: 10.1038/srep41071.

13.

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

da Silva Filho MI, Försti A, Weinhold N, Meziane I, Campo C, Huhn S, Nickel J, Hoffmann P, Nöthen MM, Jöckel KH, Landi S, Mitchell JS, Johnson D, Morgan GJ, Houlston R, Goldschmidt H, Jauch A, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO, Hemminki K.

Leukemia. 2017 Jan 13. doi: 10.1038/leu.2016.387. [Epub ahead of print]

PMID:
28025584
14.

Concordant and discordant familial cancer: Familial risks, proportions and population impact.

Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K.

Int J Cancer. 2017 Apr 1;140(7):1510-1516. doi: 10.1002/ijc.30583. Epub 2017 Jan 20.

PMID:
28006863
15.

Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression.

Li N, Johnson DC, Weinhold N, Studd JB, Orlando G, Mirabella F, Mitchell JS, Meissner T, Kaiser M, Goldschmidt H, Hemminki K, Morgan GJ, Houlston RS.

Nat Commun. 2016 Nov 24;7:13656. doi: 10.1038/ncomms13656.

16.

Identification of miRSNPs associated with the risk of multiple myeloma.

Macauda A, Calvetti D, Maccari G, Hemminki K, Försti A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martinez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudziński M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jażdżewska E, Raźny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stępień A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet-Loiseau H, Lesueur F, Grząśko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F.

Int J Cancer. 2017 Feb 1;140(3):526-534. doi: 10.1002/ijc.30465. Epub 2016 Nov 9.

PMID:
27718532
17.

A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.

Vijayakrishnan J, Kumar R, Henrion MY, Moorman AV, Rachakonda PS, Hosen I, da Silva Filho MI, Holroyd A, Dobbins SE, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson PD, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Jöckel KH, Greaves M, Harrison CJ, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS.

Leukemia. 2017 Mar;31(3):573-579. doi: 10.1038/leu.2016.271. Epub 2016 Oct 3.

18.

Common cancers share familial susceptibility: implications for cancer genetics and counselling.

Yu H, Frank C, Sundquist J, Hemminki A, Hemminki K.

J Med Genet. 2017 Apr;54(4):248-253. doi: 10.1136/jmedgenet-2016-103932. Epub 2016 Sep 20.

PMID:
27651446
19.

The epidemiology of metastases in neuroendocrine tumors.

Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K.

Int J Cancer. 2016 Dec 15;139(12):2679-2686. doi: 10.1002/ijc.30400. Epub 2016 Sep 9.

PMID:
27553864
20.

Pedigree based DNA sequencing pipeline for germline genomes of cancer families.

Försti A, Kumar A, Paramasivam N, Schlesner M, Catalano C, Dymerska D, Lubinski J, Eils R, Hemminki K.

Hered Cancer Clin Pract. 2016 Aug 9;14:16. doi: 10.1186/s13053-016-0058-1. eCollection 2016.

Supplemental Content

Loading ...
Support Center